Detalhe da pesquisa
1.
Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2.
Rheumatology (Oxford);
2024 Feb 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38331400
2.
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study.
Clin Exp Rheumatol;
41(11): 2286-2297, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37404160
3.
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis.
Rheumatology (Oxford);
61(8): 3257-3268, 2022 08 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34864911
4.
Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE.
Rheumatol Ther;
11(3): 599-615, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38498140
5.
Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower Registry.
Rheumatol Ther;
9(2): 735-751, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35279798
6.
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study.
Lancet Rheumatol;
4(4): e262-e273, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38288922
7.
Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1.
Rheumatol Ther;
8(4): 1789-1808, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34636026
8.
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study.
Rheumatol Ther;
8(2): 903-919, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33913086
9.
Correction: Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower Registry.
Rheumatol Ther;
9(5): 1477-1480, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36070073